Significance of serum IP‐10/CXCL10 measurement in predicting post‐direct acting antiviral treatment liver function in patients with HCV‐decompensated liver cirrhosis-Reference-Cited by-同舟云学术

Significance of serum IP‐10/CXCL10 measurement in predicting post‐direct acting antiviral treatment liver function in patients with HCV‐decompensated liver cirrhosis

Published:2022-12-13 Issue:4 Volume:53 Page:280-288
ISSN:1386-6346
Container-title:Hepatology Research
language:en
Short-container-title:Hepatology Research

Author:

Katoh Ryo¹,Maekawa Shinya¹^ORCID,Osawa Leona¹,Komiyama Yasuyuki¹,Nakakuki Natsuko¹,Takada Hitomi¹,Matsuda Shuya¹,Muraoka Masaru¹,Suzuki Yuichiro¹,Sato Mitsuaki¹,Tatsumi Akihisa¹,Takano Shinichi¹,Fukasawa Mitsuharu¹,Yamaguchi Tatsuya¹,Nakayama Yasuhiro¹,Inoue Taisuke¹,Enomoto Nobuyuki¹

Affiliation:

1. First Department of Internal Medicine Faculty of Medicine University of Yamanashi Chuo, Yamanashi Japan

Funder

Japan Agency for Medical Research and Development

Publisher

Wiley

Subject

Infectious Diseases,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/hepr.13861

Reference29 articles.

1. What Are the Benefits of a Sustained Virologic Response to Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection?

2. AGA Clinical Practice Update on Interaction Between Oral Direct-Acting Antivirals for Chronic Hepatitis C Infection and Hepatocellular Carcinoma: Expert Review

3. Sofosbuvir and Velpatasvir for HCV in Patients with Decompensated Cirrhosis

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk of hepatocellular carcinoma after viral clearance achieved by DAA treatment;Journal of the Formosan Medical Association;2024-01

2. Serum inducible protein 10 kDa/C‐X‐C motif chemokine 10 levels predict regression of M2BPGi‐based liver fibrosis after hepatitis C virus eradication by direct‐acting antiviral agents;Hepatology Research;2023-09-06

3. Elevated serum IP-10/CXCL10 levels are associated with sarcopenia development, a prognostic factor, in patients with primary hepatocellular carcinoma;2023-08-23

4. Impact of eradication of hepatitis C virus on liver-related and -unrelated diseases: morbidity and mortality of chronic hepatitis C after SVR;Journal of Gastroenterology;2022-12-30